| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:e103.)
© 2004 American Heart Association, Inc.
Research Report |
From Seaman Family MR Research Centre (S.B.C., A.M.D., J.E.S., A.M.B.), Foothills Medical Centre, Calgary Health Region; Departments of Clinical Neurosciences (S.B.C., A.M.D., P.A.B., W.Y.H., J.E.S., A.M.B., M.D.H.), Medicine (M.D.H.), Community Health Sciences (M.D.H.), and Radiology (W.Y.H.), University of Calgary; Calgary, Alberta, Canada.
Correspondence to Dr Shelagh Coutts, Seaman Family MR Centre, Foothills Hospital, 1403 29th St NW, Calgary, Alberta T2N 2T9, Canada. E-mail shelagh.coutts{at}calgaryhealthregion.ca
| Abstract |
|---|
|
|
|---|
Methods Two hundred fourteen patients presenting with acute ischemic stroke or transient ischemic attack were prospectively recruited if they had a brain CT scan performed within 12 hours of symptom onset. Each scan was read for ASPECTS prospectively by the treating physician and later by 1 expert reader. A weighted kappa statistic was used to determine the interobserver agreement.
Results The median baseline National Institutes of Health Stroke Scale score was 5 (range: 0 to 32) and the median time to CT scan was 152 minutes (range: 22 to 769). The interobserver agreement between ASPECTS performed in real time and expert ASPECTS was substantial (
w=0.69). The mean difference between real-time ASPECTS and expert ASPECTS was 0 (SD: 1.1).
Conclusions ASPECTS is a reliable clinical scale for rating early ischemic changes on CT when performed in real time.
Key Words: cerebral infarction computed tomography
| Introduction |
|---|
|
|
|---|
The Alberta Stroke Program Early CT Score (ASPECTS) was developed to offer a reproducible grading system to assess early ischemic changes on pretreatment CT studies in patients with acute ischemic stroke. It is a 10-point scale that grades the extent of ischemic change within the territory of the middle cerebral artery.4,5 With good training and experience, the early changes of acute ischemia in the middle cerebral artery can be detected reliably. However, previous studies of ASPECTS have been performed with consensus assessment3 or not prospectively.4 In this article, we describe the reliability of ASPECTS rated prospectively by the treating physician as compared with the ASPECTS performed at a later date by an expert rater.
| Patients and Methods |
|---|
|
|
|---|
2). Patient demographics were recorded at the time of admission to the emergency department. The protocol was approved by the local institutional ethics review board.
Imaging
Standard noncontrast CT was performed with a fourth-generation multi-slice CT scanner (GE Medical Systems) in the emergency room. The noncontrast CT scanning technique was as follows: 120 kV, 170 mA, 2-second scan time, and 5-mm slice thickness. Coverage was from skull base to vertex with contiguous axial slices parallel to the inferior orbitomeatal line. A window width of 75 to 80 Hounsfield units (HU) and window level of 30 to 40 HU were used to maximize tissue contrast. Physicians were able to alter the window width and leveling as appropriate to maximize the appearance of ischemic changes.6
Image Analysis
The ASPECTS was recorded prospectively by the treating physician at the time of CT scan. The treating physician (stroke fellow or stroke neurologist experienced in rating ASPECTS) scored the ASPECTS without knowledge of any other imaging modalities, but with knowledge of clinical symptoms. At a later point, 1 of 4 expert readers (different individual than the treating physician, including 1 neuroradiologist, 2 stroke neurologists, and 1 stroke fellow) rated the baseline CT scan using ASPECTS. The expert reader was blind to all clinical information except symptom side. Each scan was read by the treating physician, and then each scan was read later by 1 expert reader.
Statistics
Descriptive statistics were used to evaluate the study population. Interrater reliability between experts was not measured but has previously been shown to be equivalent.7 Agreement between the real-time and expert ASPECTS rating was assessed using weighted kappa (
w) scores. The weighting was designed to heavily penalize any difference >1 ASPECTS point. The
w values were interpreted as: slight agreement, 0.00 to 0.20; fair agreement, 0.21 to 0.40; moderate agreement, 0.41 to 0.60; substantial agreement, 0.61 to 0.80; or almost perfect agreement, 0.81 to 1.00.8
The distribution of ASPECTS scores (real-time and expert) was skewed. The difference between the real-time and expert ASPECTS scores was normally distributed. The unit of analysis was the difference between the real-time and expert ASPECTS. Analysis of variance was used to assess the difference between categories of real-time ASPECTS values and the difference between the real-time and expert ASPECTS. Hypothesis testing between groups was adjusted using the Bonferroni method. Linear regression was used to plot this relationship.
| Results |
|---|
|
|
|---|
Interobserver agreement between real-time and expert ASPECTS was substantial;
w=0.69 (95% confidence interval [CI]: 0.59 to 0.79). The mean difference was 0 (SD: 1.1). There was no difference in the reliability if transient ischemic attack patients were excluded (
w=0.66; n=160), or if only patients scanned at <6 hours are considered (
w=0.68; n=183), or if only stroke patients scanned at <6 hours are considered (
w=0.65; n=140).
Trichotomizing the ASPECTS scale into <3 (unfavorable), 3 to 7 (neutral), and 8 to 10 (favorable) had no impact on the mean differences between real-time and expert ASPECTS, except when the real-time ASPECTS was <3. In this situation, the expert reader was likely to call the scan
2 ASPECTS points greater than the treating physician (P=0.007 for 3 to 7; P<0.001 for 8 to 10). There was a trend toward the treating physician undercalling the ischemic change in the 8-to-10 group, ie, the treating physician gives a clinically more favorable score than does the expert. However, this did not reach statistical significance (P=0.064). This relationship was not affected by age, blood glucose, or the baseline NIHSS score.
Figure 1 gives a graphic representation of the correlation between the real-time ASPECTS and the difference between the real-time ASPECTS and the expert ASPECTS. The slope of the line suggests that, at lower real-time ASPECTS ratings, there is a trend for the treating physician to overinterpret the presence of ischemic change (Figure 2).
|
|
| Conclusions |
|---|
|
|
|---|
At higher ASPECTS (>7) scores (favorable scan appearance), the real-time observer tends to undercall ischemic change. The effect size is quite small and is likely to be clinically insignificant. At lower ASPECTS (<3) scores (unfavorable scan appearance), the real-time observer tends to overcall the ischemic change by nearly 2 points. The reasons for this probably reflect a combination of factors, including the human visual perception systems tendency to overestimate boundaries.10 Human factors such as a desire not to administer thrombolysis may also spur the real-time observer to naturally err toward lower scores. There was no relationship between NIHSS and the differences seen between the real-time and expert ASPECTS. This suggests that the real-time physician does not overcall ischemic change because of bias introduced by knowledge of stroke severity. At the high end of the scale, the physician may be keen to offer thrombolysis and underinterpret the ischemic change. A final reason for disparity in scoring between the real-time and expert rating is that the treating physician often does not have ideal conditions for the rating of brain CT scan.
A weighted kappa was used for the statistics because artificially dichotomizing the results into >7 and
7 would overly penalize a scan that an expert called a 7 and that the treating physician called a 6. A score of ±1 point on the ASPECTS scale has been to shown to the expected margin of error,7 is felt not to be clinically significant, and would not deter thrombolytic treatment for any given patient. Hence, the kappa score was weighted to penalize any difference more than ±1 point. Our population included patients with transient ischemic attack and patients who were imaged between 6 and 12 hours after symptom onset. However, removing these patients from the analysis made no difference to agreement.
The results in our study are limited to stroke neurologists and neuroradiologists. We did not assess the ability of emergency physicians or trainees to rate ASPECTS. This is an important limitation and future work is needed in this area.
In conclusion, we have found that ASPECTS performed in real time is a reliable method of quantifying the early ischemic changes of the middle cerebral artery in acute stroke.
| Acknowledgments |
|---|
Received November 20, 2003; accepted January 21, 2004.
| References |
|---|
|
|
|---|
2. Von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, Bluhmki E, Ringleb P, Meier DH, Hacke W. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology. 1997; 205: 327333.
3. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM; PROACT-II Investigators. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke. 2003; 34: 19251931.
4. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet. 2000; 355: 16701674.[CrossRef][Medline] [Order article via Infotrieve]
5. Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, Hu WY, Buchan AM. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol. 2001; 22: 15341542.
6. Lev MH, Farkas J, Gemmete JJ, Hossain ST, Hunter GJ, Koroshetz WJ, Gonzalez RG. Acute stroke: improved nonenhanced CT detectionbenefits of soft-copy interpretation by using variable window width and center level settings. Radiology. 1999; 213: 150155.
7. Hill MD, Barber PA, Hudon ME, Pexman, JHW. Inter- and intra-observer reliability of ASPECTS. Stroke. 2003; 34: 281. Abstract.
8. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977; 33: 159174.[CrossRef][Medline] [Order article via Infotrieve]
9. Albers GW, Caplan LR, Easton JD, Fayad PB, Mohr JP, Saver JL, Sherman DG; TIA Working Group. Transient ischemic attack-proposal for a new definition. N Engl J Med. 2002; 347: 17131716.
10. Mitchell JR, Karlik SJ, Lee DH, Fenster A. Computer assisted identification and quantification of multiple sclerosis lesions in MR imaging volumes in the brain. J Magn Res Imag. 1994; 4: 197208.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
O. C. Singer, W. Kurre, M. C. Humpich, M. W. Lorenz, A. Kastrup, D. S. Liebeskind, G. Thomalla, J. Fiehler, J. Berkefeld, T. Neumann-Haefelin, et al. Risk Assessment of Symptomatic Intracerebral Hemorrhage After Thrombolysis Using DWI-ASPECTS Stroke, August 1, 2009; 40(8): 2743 - 2748. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Butcher, M. Parsons, L. Allport, S. B. Lee, P. A. Barber, B. Tress, G. A. Donnan, S. M. Davis, and for the EPITHET Investigators Rapid Assessment of Perfusion-Diffusion Mismatch Stroke, January 1, 2008; 39(1): 75 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.D. Hill, A.M. Demchuk, T.A. Tomsick, Y.Y. Palesch, J.P. Broderick, and on behalf of the IMS-1 Investigators Using the Baseline CT Scan to Select Acute Stroke Patients for IV-IA Therapy. AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1612 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Dzialowski, M. D. Hill, S. B. Coutts, A. M. Demchuk, D. M. Kent, O. Wunderlich, and R. von Kummer Extent of Early Ischemic Changes on Computed Tomography (CT) Before Thrombolysis: Prognostic Value of the Alberta Stroke Program Early CT Score in ECASS II Stroke, April 1, 2006; 37(4): 973 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Dittrich, M. A. Ritter, M. Kaps, M. Siebler, K. Lees, V. Larrue, D. G. Nabavi, E. B. Ringelstein, H. S. Markus, and D. W. Droste The Use of Embolic Signal Detection in Multicenter Trials to Evaluate Antiplatelet Efficacy: Signal Analysis and Quality Control Mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) Trial Stroke, April 1, 2006; 37(4): 1065 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Demchuk, M. D. Hill, P. A. Barber, B. Silver, S. C. Patel, S. R. Levine, and for the NINDS rtPA Stroke Study Group, NIH Importance of Early Ischemic Computed Tomography Changes Using ASPECTS in NINDS rtPA Stroke Study Stroke, October 1, 2005; 36(10): 2110 - 2115. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Adams, R. Adams, G. Del Zoppo, and L. B. Goldstein Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association Stroke, April 1, 2005; 36(4): 916 - 923. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |